Boston Scientific Corp.

"Jim Tobin joined Boston Scientific as President and Chief Executive Officer in 1999, bringing with him health care industry leadership and vision that has helped the company build on its dramatic growth. Jim is driving Boston Scientific’s strategic efforts to continue its global leadership position in the field of less-invasive medicine. The company develops, manufactures and markets less-invasive medical devices for use in a broad range of interventional medical specialties. Before joining Boston Scientific, Jim was President and Chief Executive Officer of Biogen, Inc. He managed Biogen’s research and development, manufacturing, marketing and sales. He joined Biogen as President and Chief Operating Officer in 1994 and became President and CEO in 1997. He also served on Biogen’s Board of Directors. Previously, Jim spent 22 years with Baxter International, rising from financial analyst to President and Chief Operating Officer. Between 1972 and 1994, he served as Managing Director in Japan (1975-1977) and Spain (1977-1980), and President of the I.V. Systems Group (1981-1986). He was promoted to Executive Vice President, responsible for running a worldwide business group, in 1988 and became responsible for Baxter’s manufacturing and distribution business in 1990. He served as President and Chief Operating Officer of the 60,000-employee, $9 billion company from 1992 until 1994. Jim serves on the boards of Boston Scientific Corporation, and Curis, Inc., and is involved with the BioMedical Science Career Program. He also served as lieutenant in the U. S. Navy from 1968 to 1972. He holds an A.B. from Harvard College and an M.B.A. from Harvard Business School. "

"John Pedersen is President of the Urology and Gynecology business at Boston Scientific Corporation. Prior to assuming this role, John was President of the Company’s Peripheral Interventions (PI) business. John lead the PI business through a challenging period of implementing continuous quality improvement programs in the face of increased competition in the market. During this period, he refocused the business strategy to key growth areas within PI with special emphasis on interventional cardiologists and vascular surgeons. Ultimately, John and his team helped combine the PI business unit into a larger cardiovascular group. Prior to his role as President of PI, John served as President of Boston Scientific’s Urology and Gynecology business. Heavy investments were made to sustain leadership in Urology and build a Gynecology business during his first tenure as President. Sales doubled for the business during this period to more than $300 million. Previously, John was President of the Company’s Neurovascular business. He joined the Company in 1996 as Director of New Business Development. Before joining Boston Scientific, John was a Senior Engagement Manager for McKinsey & Company. John earned a B.A. from Princeton University, completed coursework with Thomas Jefferson Medical College, and earned an M.B.A. from Harvard Business School. He is a member of the New England Chapter of the Young President’s Organization. "

"Joe Fitzgerald is President and General Manager of the Peripheral Interventions business at Boston Scientific Corporation with overall responsibility for our peripheral vascular and neurovascular business units. Prior to his current role, Joe was President of the Company’s Electrophysiology business. In this role, the business experienced double-digit sales and profitability growth and maintained its market-leading position in the catheter ablation market segment. Previously, Joe held a variety of management positions in Boston Scientific’s Neurovascular and Peripheral Interventions businesses. This included numerous regional and divisional sales management assignments up to and including his roles as Vice President, Global Marketing and U.S. Sales for the Neurovascular business. Joe joined Boston Scientific in 1990 as a sales representative. Prior to joining the Company, Joe was with Anheuser Busch, Inc., where he held a variety of sales, marketing, and training assignments. Joe earned a B.S. in Business from Indiana University and an M.B.A. from Southern Illinois with a concentration in marketing and finance. "

"Mark Paul is President of Neurovascular at Boston Scientific Corporation. Mark joined Boston Scientific in 1991 as territory manager for its Medi-Tech division. Most recently, he served as Vice President and General Manager of Boston Scientific International, leading 10 international business franchises and marketing support functions. Previously, Mark held a variety of marketing positions in the Company's Peripheral Interventions, Neurovascular, Oncology and Vascular Surgery businesses. He was Boston Scientific's first Neurovascular product manager and subsequently held a series of marketing positions with increasing management responsibility, including Director of Marketing in Europe for the Company's Peripheral Interventions, Oncology and Vascular Surgery businesses. Prior to Boston Scientific, Mark held a variety of sales management positions with Procter & Gamble's paper and soap divisions. Mark earned a B.A. in English Literature Studies from the University of Utah where he spent time at the Universite de Neuchatel in Switzerland and Cambridge University in England. "

"Maulik Nanavaty is President of Boston Scientific Japan at the Boston Scientific Corporation. Maulik joined Boston Scientific in 2005 as Vice President for Corporate Strategy for Japan, where he led a successful business transformation and contributed to a high level of operational efficiency. Most recently, Maulik was Vice President and General Manager of Japan's Interventional Cardiology business. During his tenure, Maulik managed the successful launch of the Company’s TAXUS® Express2™ drug-eluting stent system in Japan. Prior to joining Boston Scientific, Maulik served for 16 years in various executive positions at Baxter International, Inc., and Baxter Japan. Maulik holds a Ph.D. in Pharmaceutical sciences from the University of Illinois and a M.B.A. from the University of Chicago. "

"Michael Onuscheck is Senior Vice President and President of the Neuromodulation business at Boston Scientific Corporation. Michael joined the Company in 2004 with the Boston Scientific acquisition of Advanced Bionics as the Vice President of Sales and Clinical Services in the Company’s Auditory business. Most recently he was Vice President of Sales and Marketing for the Boston Scientific’s Pain Management business. In this role, he lead the commercial launch of the Precision™ Spinal Cord Stimulator for intractable pain, and helped launch the spinal cord stimulation business at Boston Scientific. During his tenure, Michael led the field sales and clinical organization, marketing and communications function, field clinical engineering team, technical support team, and training and education department. Previously, Michael held a variety of management positions at Medtronic in spinal reconstructive surgery and stereotactic image guided surgery. Prior to Medtronic, he worked for Pfizer Inc., where he held a variety of sales and marketing assignments. Michael earned a B.A. in Business Administration Psychology from Washington and Jefferson College. "

"Tony Gibbons is Regional President of Inter-Continental at Boston Scientific Corporation, which includes Japan, Asia, Latin America and Canada. Tony joined the Company in 1991 as an Endoscopy sales representative responsible for the Company's Florida territory and most recently was Vice President, International Sales and General Manager. In this role, he was responsible for overall sales execution of the business, which included training and developing more than 1,200 sales representatives and 400 sales managers in 67 countries. He was also responsible for the Company's Canadian operations overseeing more than 125 employees. Previously, he was Vice President and General Manager of the Company's operations in Latin America and Canada, where he increased sales growth by 75 percent. Prior to this, Tony was Country Director of the Company's Canada operations. Prior to Boston Scientific, Tony was with Harris/Lanier Corporation, where he held a variety of sales and sales management roles. Tony earned a B.S. in both Economics and Marketing from Alfred University in 1987. "

"Donald S. Baim, M.D., is Executive Vice President, Chief Medical and Scientific Officer at Boston Scientific Corporation as of July 3, 2006. Dr. Baim's primary responsibilities include management of Clinical Affairs (including pre-clinical and clinical studies); Medical Affairs (including educational programs and physician relationships), and Safety. He also plays a major role in developing technology strategies, including the assessment of technologies of acquisition and partnership candidates, and their integration with internal technologies to help develop the Company's future product portfolio. Before joining Boston Scientific, Dr. Baim was a Professor of Medicine at Harvard Medical School, Senior Physician at the Brigham and Women's Hospital, and an internationally recognized leader in interventional cardiology who specialized in the development and evaluation of new interventional cardiovascular devices. He has published nearly 300 scientific papers on interventional cardiology, edited the leading textbook in the field (Grossman's Cardiac Catheterization, Angiography and Intervention, now in its 7th edition), and has served as a member of the Interventional Cardiology Test Committee of the American Board of Internal Medicine (ABIM). Dr. Baim has been the national Principal Investigator on literally dozens of clinical trials in interventional cardiology, and a founder or key consultant for more than 20 start-up companies and medical device incubators in areas ranging from embolic protection, thrombectomy, chronic total occlusions, arterial closure, novel stent and coatings, heart failure, and percutaneous heart valves. He was the recipient of the Career Achievement Award at TCT 2000, based on his clinical, research, and educational contributions to the field. Dr. Baim completed his undergraduate training in Physics at the University of Chicago, and then received a M.D. from Yale University School of Medicine. During post-graduate training in medicine and cardiology at Stanford, he worked with Dr. John Simpson during the development of some of the earliest moveable guidewire coronary angioplasty catheters. In 1981, Dr. Baim was recruited to establish an Interventional Cardiology program at Boston's Beth Israel Hospital. Under his leadership, this program went on to perform seminal research in the refinement, critical evaluation and optimal application of newer devices, including stents, atherectomy, clot removal and distal embolic protection. In 2000, he was recruited by the Brigham and Women's Hospital in Boston, where in addition to his clinical responsibilities, he directed the hospital's participation in the Center for the Integration of Medicine and Innovative Technology (CIMIT), a federally funded inter-disciplinary consortium of leading Boston teaching hospitals and engineering institutions that develops innovative device solutions for a wide range of unmet medical challenges. Since 2005, Dr. Baim has also served as Chief Academic Officer of the Harvard Clinical Research Institute (HCRI), a not-for-profit organization that designs, conducts, and analyzes pilot and pivotal trials of new medical devices to support their approval by the U.S. Food and Drug Administration (FDA). "

"Fred Colen is Executive Vice President and Group President of Cardiac Rhythm Management (CRM) at Boston Scientific Corporation. Previously, Fred was the Company’s Executive Vice President, Operations and Technology for CRM. He joined the Company in 1999 as Vice President of Research and Development of Scimed. In 2001 he was promoted to Senior Vice President, Cardiovascular Technology of Scimed and later appointed Senior Vice President and Chief Technology Officer. Before joining the Company, Fred worked for several medical device companies, including Guidant, where he launched the Delta T DDD Pacemaker platform, and St. Jude Medical, where he served as Managing Director for the European subsidiary of the Cardiac Rhythm Management Division and as Executive Vice President, responsible for worldwide Research & Development for implantable pacemaker systems. Fred was educated in The Netherlands and Germany and holds the U.S. equivalent of a master's degree in Electrical Engineering with a focus on medical technology from the Technical University in Aachen, Germany. He was the Vice President of the International Association of Prosthesis Manufacturers (IAPM) in Brussels from 1995 to 1997. "

Previously, Jeff was President of the Inter-Continental business at Boston Scientific. In that role, he was responsible for management of Boston Scientific business in Eastern Europe, the Middle East, Africa, Asia, the Pacific, South America, and Canada. These geographies cover 60 countries on six continents. During his tenure, Inter-Continental's revenues quintupled and profits increased dramatically.

"Jim Gilbert is Executive Vice President, Strategy and Business Development at Boston Scientific Corporation. In this role, Jim oversees the Company's Business Development, Marketing Science, E-Marketing, and Health Economics and Reimbursement functions. He also has responsibility for directing and supporting the corporate strategy process. Prior to this role, Jim served as Group President of the Cardiovascular Group, which included the Company's Peripheral Interventions, Vascular Surgery, Neurovascular, Electrophysiology, and Cardiac Surgery businesses. Previously, Jim spent 23 years at Bain & Company, where he served as Director and Partner, based in Boston, Massachusetts and Munich, Germany. From 1990 to 2003 he was the Global Healthcare Practice Managing Partner working on strategic, operational and organizational projects with medical technology, diagnostic, pharmaceutical, biotechnology, analytic instrumentation, information technology, distribution and alternate site and hospital provider clients. He was also an elected member and chairman of all three of Bain's partner leadership committees, including the Partner Compensation and Promotion Committee, Partner Management Committee and Partner Nominating and Governance Committee. Jim graduated from Cornell University School of Engineering where he earned a B.S. in industrial engineering and operations research with high distinction. He earned an M.B.A. with distinction from Harvard Business School. "

Lucia Quinn is Executive Vice President of Human Resources at Boston Scientific Corporation. Lucia joined the Company in 2005 and is responsible for company-wide Human Resources efforts, including HR services to all Boston Scientific businesses and functions, as well as corporate recruiting, compensation, benefits, policies, and training. Previously, Lucia was Senior Vice President at Quest Diagnostics Incorporated, a provider of diagnostic testing, information and services. She joined Quest in 2001 as a member of the senior management team and was responsible for a portfolio of businesses with approximately $1 billion in revenue, and for directing investments, acquisitions, product development and key customer contracts. Prior to joining Quest, Lucia was Vice President, Corporate Strategic Marketing for Honeywell International, where she oversaw Honeywell's business portfolio analysis and strategic marketing groups. Previously, Lucia held a variety of leadership positions in global technology companies Westinghouse, Digital Equipment, Compaq and AlliedSignal. Lucia graduated from Simmons College where she earned a B.A. in Management. She currently chairs the Board of Trustees at Simmons College and is an overseer of the Museum of Science in Boston. Lucia is also a member of The Committee of 200, an organization of leading businesswomen.

"Tim Pratt is Executive Vice President, Secretary and General Counsel at Boston Scientific Corporation. Tim joined Boston Scientific in May of 2008 where he is responsible for worldwide management of the Company’s legal functions. Previously, Tim worked for the law firm of Shook, Hardy & Bacon. He joined the firm in 1977 and became partner in 1981. He concentrated his practice in the defense of pharmaceutical and medical device litigation and toxic tort cases. Tim was co-chair of Shook, Hardy’s 100-attorney Pharmaceutical and Medical Device Litigation Division. Tim has been named to the 2008 BTI Client Service All-Star Team for Law Firms, an exclusive group of 148 attorneys recognized by Fortune 1,000 companies who stand above all others for superior and unparalleled client service, knowledge and value in their area of expertise. In 2006 and 2007, he was named a Leading National Products Liability Lawyer by Chambers USA and was described as “outstanding by any measure.” Tim is listed in “The Best Lawyers in America,” was selected as a Top 100 “Super Lawyer” in Missouri and Kansas, and was recognized by Lawdragon as one of the Top 500 Litigators in America. Tim is active in the Federation of Defense and Corporate Counsel, where he serves as a director on their board. He is also active in the American Bar Association and speaks regularly at the Defense Research Institute (DRI), where he has served as chair of the DRI Corporate Counsel Roundtable and as a member of the DRI Civil Rules Advisory Committee. For over 20 years, Tim has served on the faculty for the National Institute for Trial Advocacy, and he currently serves on the editorial advisory board for the BNA, Inc. publication, Medical Devices Law & Industry Report. Tim received his Bachelor of Arts degree at Tarkio College and graduated Order of the Coif from Drake University Law School, where he served one year as editor-in-chief of the Drake Law Review. After graduating, Tim was law clerk to Judge Floyd R. Gibson of the U.S. Court of Appeals for Eighth Circuit. "

"David McFaul is Senior Vice President of International at Boston Scientific Corporation. Prior to this role, David was Regional President of Asia-Pacific & Japan operations. He joined the Company in 1995 to oversee the development of the Company's Canadian business and most recently was President of the Company's Japan operations. Prior to this, David was Vice President of Sales, Inter-Continental. In this role, he was responsible for overall sales execution for the businesses, which included training and developing more than 400 sales representatives and 85 sales managers in 35 countries. He also implemented a new ""on-boarding"" program for new hires, developed a clinical training program, and created a high-performance sales management program for the Inter-Continental business. Previously, he was Vice President and General Manager of the Company's operations in Latin America, Canada and South Africa where he increased revenue nearly 50 percent. Prior to this, David was General Manager, Canada and South Africa, Country Manager of Canada and National Sales Manager, Canada for the Company. Prior to Boston Scientific, David held sales, marketing and general management positions at a variety of medical-related companies including Stryker Corporation, EBI Medical Systems, Baxter Corporation, and Abbott Labs. David earned a B.A. in History and Geography from Simon Fraser University and took graduate courses at Simon Fraser University Graduate School. "

Joel L. Fleishman has been a Director of Boston Scientific since 1992. He is also Professor of Law and Public Policy at Duke University where he has served in various administrative positions, including First Senior Vice President, since 1971. Mr. Fleishman is a founding member of the governing board of the Duke Center for Health Policy Research and Education and was the founding director from 1971 to 1983 of Duke University's Terry Sanford Institute of Public Policy. He is the director of the Samuel and Ronnie Heyman Center for Ethics, Public Policy and the Professions and the director of the Duke University Philanthropic Research Program. From 1993 to 2001, Mr. Fleishman took a part time leave from Duke University to serve as President of the Atlantic Philanthropic Service Company, the U.S. program staff of Atlantic Philanthropies. Mr. Fleishman also serves as a member of the Board of Trustees of The Center for Effective Philanthropy and the Partnership for Public Service, Chairman of the Board of Trustees of the Urban Institute, Chairman of The Visiting Committee of the Kennedy School of Government, Harvard University, and as a director of Polo Ralph Lauren Corporation. Mr. Fleishman received A.B., M.A. and J.D. degrees from the University of North Carolina at Chapel Hill, and an LL.M. degree from Yale University.

Mark C. Bartell is Senior Vice President, Global Sales & Marketing for CRM at Boston Scientific Corporation. Prior to his current assignment, Mark served as President of the United States Sales Operations at the Guidant Corporation. Prior to this role, he served as Vice President, Marketing for Guidant's Cardiac Rhythm Management group and Vice President and General Manager of the guide wire business unit at Guidant's Vascular Intervention group. Mark joined Cardiac Pacemakers Inc., which became part of Guidant's Cardiac Rhythm Management group, in 1985 as a Financial Analyst. He held positions in new product planning, product management and as a Sales Representative. Mark earned his B.S. degree from the University of Florida, and a Master of Business Administration from the University of Michigan.

"Paul Donovan is Senior Vice President for Corporate Communications at Boston Scientific Corporation. He is responsible for the Company’s communications activities, including media relations, employee communications and brand identity. He also serves as the Company’s spokesman. Paul brings more than 25 years of communications experience to Boston Scientific. Before joining the Company in 2000, he was Executive Director of External Affairs at Georgetown University Medical Center. Previously he was Chief of Staff at the U.S. Department of Commerce. He served for 10 years on the staff of Senator Edward M. Kennedy, first as Press Secretary and later as Chief of Staff. Prior to that he served as a press aide to Senator John F. Kerry. He holds a B.A. from Dartmouth College. He serves on the Board of Directors of the Massachusetts Medical Device Industry Council and the Massachusetts High Tech Council, and he is an Overseer of Children’s Hospital in Boston. "

Steve Moreci is Senior Vice President and Group President for Endosurgery responsible for Boston Scientific's Endoscopy, Urology/Gynecology and Oncology businesses. Steve joined Boston Scientific in 1989 as Vice President and General Manager for the Cardiac Assist business. In 1991, he was appointed Vice President and General Manager for the newly formed Endoscopy business. In 1994, Steve was given the additional responsibility for the company's Urology and Gynecology business and was promoted to Group Vice President. By 1997, the Endoscopy business had grown from $19 million to over $300 million, recording six years of double-digit global growth. In recognition of his accomplishments and to enable Steve to focus full time on the growing Endoscopy business, Steve was promoted to President, Endoscopy. In 1999, Steve was named President of the Boston Scientific's Vascular business, which included Peripheral Interventions, Vascular Surgery, and Oncology. In 2000 and 2001, he helped successfully transfer the Peripheral Interventions and the Vascular Surgery businesses to the Cardiovascular Group. In 2000, Steve recommended the establishment of a new business group, Endosurgery, to provide focus on the significant growth opportunities in emerging Quality of Life technologies and in Women's Health. In late 2000, Steve was promoted to the Boston Scientific Executive Committee and was named Senior Vice President and Group President for Endosurgery. Prior to his joining Boston Scientific, Steve enjoyed a 13-year career in Medical Devices including 9 years with Johnson and Johnson, where he held a variety of sales and marketing positions. From 1985 to his joining Boston Scientific, Steve was Vice President of Sales and Marketing for DermaCare, a small medical device firm that supplied finished goods and components to a variety of multi-national medical device firms including Zimmer and Baxter. He holds a B.S. in Marketing from Pennsylvania State University.

"William F. McConnell, Jr. (Bill) is Vice President for Sales, Marketing and Business Strategy, CRM at Boston Scientific Corporation. Prior to his current assignment, Bill was Senior Vice President, Administration, CRM at Boston Scientific Corporation and Vice President and Chief Information Officer for Guidant Corporation. Previously, Bill was Managing Partner - Business Consulting in the Indianapolis office of Arthur Andersen LLP. He joined Arthur Andersen in 1971 as a staff member involved in consulting with clients in the planning, design and implementation of information systems. Bill was promoted to manager in 1975 and then was admitted as a Partner in Arthur Andersen in 1981. He became the Managing Partner - Andersen Consulting in Indianapolis in 1983 and ran the Indiana practice for the firm for the next six years. In 1989, he left Andersen to join Resort Condominiums International (RCI) as Chief Financial Officer. He spent a year as CFO, was promoted to Chief Operating Officer in 1990 and spent the next six years running North American operations for RCI. He became Information Officer/Worldwide for RCI in 1996. He left RCI in 1997 when it was acquired by HFS and rejoined Arthur Andersen in 1997. Bill serves as a board member of the Global Healthcare Exchange, Vesalius Ventures, and Board of Governors of the National American Red Cross. He is the Chairman of the Board of Trustees for the Trustee Leadership Development and Honorary Trustee of the Children’s Museum of Indianapolis. He is also a board member of the Information Technology Committee of Community Hospitals of Indianapolis, Inc., the Indiana University Information Technology Advancement Council, and ex officio member of the Board of Directors for the American Red Cross of Greater Indianapolis. Bill received a B.S. degree from Miami University in Oxford, Ohio. He majored in Systems Analysis and he is also a Certified Public Accountant. "

"Hank Kucheman is Senior Vice President and Group President of the Interventional Cardiology Group at Boston Scientific Corporation. Hank joined the Company in 1995 as a result of the merger between Boston Scientific and SCIMED Life Systems, Inc. and most recently was Senior Vice President of Marketing for Boston Scientific. In this role, he was responsible for the global marketing functions of the Company’s Cardiovascular group and all Corporate Marketing functions. He oversaw the commercialization strategy for the Company’s TAXUS® paclitaxel-eluting coronary stent system, defined and developed the Boston Scientific Medical Affairs organization and initiated best-in-class Marketing Science and e-Marketing programs. Prior to that, Hank was Vice President, Corporate Marketing and Vice President, Strategic Marketing for the Company. Prior to joining Boston Scientific, Hank held a variety of management positions in sales and marketing for SCIMED Life Systems, Inc., Charter Medical Corporation, and Control Data Corporation. He began his career at the United States Air Force Academy Hospital and later was Healthcare Planner, Office of the Surgeon General, for the United States Air Force Medical Service. Hank has served on several industry boards including the board of directors of the Global Health Exchange, the Committee on Payment and Policy, and AdvaMed. He has also served on the Board of Advisors to MillenniumDoctor.com and the Board of Advisors to the College of Business, Center for Services Marketing and Management, Arizona State University. Hank earned a B.S. and a M.B.A. from Virginia Polytechnic Institute and State University. "

As the first employee and member of the executive management team at DispenseSource, Inc., he helped raised $10 Million from two venture capital groups and set out to build the infrastructure of the company. The Company then repurposed the automated inventory control systems that he helped pioneer at Pyxis, and successfully introduced it to a new market segment of Fortune 500 companies. As a Vice President and member of the executive management team at Pyxis Corp., which sells automated inventory control systems for medicines and medical supplies, he oversaw sales and operations. His duties included managing the sales team, engineers, nurses, pharmacists and installation technicians while ultimately attaining a 90% market share. As a result, in 1995 INC. Magazine listed Pyxis as the fastest growing company in the U.S. Mr. Curtis worked closely with the investment community and key industry decision makers in building the company s valuation, and in 1996 it was sold to Cardinal Healthcare for $1 Billion. Curtis also held the position as the Director of Sales of Pancretec, which manufactures ambulatory infusion pumps for patient delivery of intravenous fluids. In a turn-around effort, Curtis led the company to its first eight consecutive quarters of profitability and growth. The following year, based on revenues of $4 Million, Abbott Labs acquired the company for $58 Million.Additional work experience includes: Chief Operating Officer/VP Marketing of RealSim Medical (Simulation Software); Vice President Sales & Marketing of Alteer Corp. (Medical Software/HIS); and Regional Manager/Distribution Center Manager of Medi-Tech/Boston Scientific (Interventional Radiology/Surgical).Mr. Curtis holds a Bachelor of Arts in Marketing from the University of South Florida.

Dr. Wiener practices vascular and interventional radiology full-time. He is Chief of Vascular and Interventional Radiology at Phoenix Baptist Hospital and Arizona Medical Imaging. Dr. Wiener specializes in vascular and interventional radiology procedures such as arteriography/angiography, angioplasty/stents, uterine fibroid embolization, vertebroplasty, implanted venous devices, biopsies, and biliary/urinary drainages. In addition to running a busy practice, Dr. Wiener is the Phoenix Legs for Life Screening Coordinator and a lecturer and physician trainer for Boston Scientific Corporation and Centecor Corporation. He is a residency Preceptor at Phoenix Baptist Hospital, and a member of multiple committees of the Society of Cardiovascular and Interventional Radiology (SCVIR). Dr. Wiener earned his medical degree at the New Jersey School of Osteopathic Medicine. He completed his residency at Kennedy Memorial Hospital in Stratford, New Jersey, and his fellowship at West Penn Hospital in Pittsburgh, Pennsylvania. He is Board Certified in diagnostic radiology and has a Certificate of Additional Qualification in vascular and interventional radiology. When not seeing patients, teaching, or participating in the medical community, Dr. Wiener enjoys photography, cooking, traveling, and reading. Dr. Wiener practices at Baptist Hospital and Medical Center in Phoenix, Arizona.

Timothy J. O'Shea has served as a member of our board of directors since April 2004. Since joining Boston Scientific in 1981, he has served in a variety of management positions, including business development, corporate project management, international and domestic marketing and sales. Mr. O'Shea currently serves as a board member or observer on behalf of Boston Scientific for several private and public companies. Mr. O'Shea holds a B.A. in history from the University of Detroit.

Pete M. Nicholas, our co-founder, has been Chairman of the Board since 1995. He has been a Director since 1979 and served as our Chief Executive Officer from 1979 to March 1999 and Co-Chairman of the Board from 1979 to 1995. Prior to joining Boston Scientific, he was corporate director of marketing and general manager of the Medical Products Division at Millipore Corporation, a medical device company, and served in various sales, marketing and general management positions at Eli Lilly and Company. He is currently Chairman Emeritus of the Board of Trustees of Duke University. Mr. Nicholas is also a Fellow of the American Academy of Arts and Sciences and Vice Chairman of the Trust for that organization. He also serves on several for profit and not for profit boards including CEOs for Fundamental Change in Education and the Boys and Girls Club of Boston. After college, Mr. Nicholas served as an officer in the U.S. Navy, resigning his commission as lieutenant in 1966. Mr. Nicholas received a B.A. degree from Duke University, and an M.B.A. degree from The Wharton School of the University of Pennsylvania. He is the brother of N.J. Nicholas, Jr., one of our directors.

J. Raymond Elliott became a Director of Boston Scientific in September 2007. Mr. Elliott was the Chairman of Zimmer Holdings, Inc. until November 2007 and was President and Chief Executive Officer of Zimmer Holdings, Inc. from March 2001 to May 2007. Mr. Elliott was appointed President of Zimmer, Inc. in November 1997. Mr. Elliott has more than 35 years of experience in orthopedics, medical devices and consumer products. He has served as a director on more than 20 business-related boards in the U.S., Canada, Japan and Europe and has served on six occasions as Chairman. He has served as a member of the board of directors and chair of the orthopedic sector of the Advanced Medical Technology Association (AdvaMed) and is a director of the Indiana Chamber of Commerce, and the American Swiss Foundation and Bausch & Lomb Corporation. Mr. Elliott has served as the Indiana representative on the President's State Scholars Program and as a trustee of the Orthopaedic Research and Education Foundation (OREF). He holds a bachelor's degree from the University of Western Ontario, Canada.

N.J. Nicholas, Jr. has been a Director of Boston Scientific since 1994 and is a private investor. Previously, he served as President of Time, Inc. from September 1986 to May 1990 and Co-Chief Executive Officer of Time Warner, Inc. from May 1990 until February 1992. Mr. Nicholas is a director of Xerox Corporation and Time Warner Cable, Inc. He has served as a member of the President's Advisory Committee for Trade Policy and Negotiations and the President's Commission on Environmental Quality. Mr. Nicholas is Chairman of the Board of Trustees of the Environmental Defense Fund and a member of the Council of Foreign Relations. Mr. Nicholas received an A.B. degree from Princeton University and an M.B.A. degree from Harvard Business School. He is the brother of Pete M. Nicholas, Chairman of the Board.

Ray J. Groves has been a Director of Boston Scientific since 1999. Effective February 16, 2009, Mr. Groves became the Ombudsman for Standard & Poor’s. From 2001 to 2005, Mr. Groves served in various roles at Marsh Inc., including President, Chairman and Senior Advisor, and is a former member of the board of directors of its parent company, Marsh & McLennan Companies, Inc. He served as Chairman of Legg Mason Merchant Banking, Inc. from 1995 to 2001. Mr. Groves served as Chairman and Chief Executive Officer of Ernst & Young for 17 years until his retirement in 1994. Mr. Groves currently serves as a member of the boards of directors of the Colorado Physicians Insurance Company and Group Ark Insurance Holdings, Ltd. Mr. Groves is a member of the Council on Foreign Relations. He is a former member of the Board of Governors of the American Stock Exchange and the National Association of Securities Dealers. Mr. Groves is former Chairman of the board of directors of the American Institute of Certified Public Accountants. He is a director of Nursing and Home Care, Inc., a member and former Chair of the board of directors of The Ohio State University Foundation and a member of the Dean's Advisory Council of the Fisher College of Business. He is a former member of the Board of Overseers of The Wharton School of the University of Pennsylvania and served as the Chairman of its Center for the Study of the Service Sector. Mr. Groves is an advisory director of the Metropolitan Opera Association and a director of the Collegiate Chorale. Mr. Groves received a B.S. degree from The Ohio State University.

Ursula M. Burns is president of Xerox Corporation. She was named to this position in April 2007. She is also a member of the Xerox Board of Directors, elected in April 2007. Burns is responsible for the company's global research, development, engineering, marketing and manufacturing of Xerox technology, supplies and related services. She also oversees for the corporation Global Accounts, Information Management, Corporate Strategy, Human Resources and Ethics, and Marketing Operations. Burns joined Xerox in 1980 as a mechanical engineering summer intern. She since held several positions in engineering including product development and planning. In June 1991, she became the executive assistant to Paul A. Allaire, then Xerox chairman and chief executive officer. From 1992 through 2000, Burns led several business teams including the office color and fax business, office network copying business, and the departmental business unit. In May 2000, she was named senior vice president, Corporate Strategic Services, and two years later assumed the role of president, Business Group Operations. She serves on professional and community boards, including American Express Corp., Boston Scientific Corp., CASA - The National Center on Addiction and Substance Abuse at Columbia University, FIRST - (For Inspiration and Recognition of Science and Technology), National Academy Foundation, MIT, the U.S. Olympic Committee and the University of Rochester.

Warren Rudman was born May 18, 1930 in Boston, Massachusetts and was an American Senator from New Hampshire. He was elected as a Republican in 1980 and re-elected in 1986, and was known as a pragmatic centrist. He chose not to run for re-election in 1992. Rudman is now a retired partner in the international law firm Paul, Weiss, Rifkind, Wharton, and Garrison. He currently sits on the board of directors of Raytheon, Collins & Aikman, Allied Waste Corporation, Boston Scientific and a number of funds in the Dreyfus Family of Funds. Rudman has lived his entire life in New Hampshire, with few exceptions. He attended the Valley Forge Military Academy boarding school in Wayne, PA. He received his undergraduate degree from Syracuse University, and served in the United States Army during the Korean War. He received his law degree from Boston College Law School in 1960, and was appointed Attorney General of New Hampshire in 1970. From 2004-2006, Rudman also led a committee that investigated accounting practices at Fannie Mae. Prior to the September 11, 2001 attacks, Senator Rudman had served on a now-oft-cited and praised national panel investigating the threat of international terrorism. He, along with fellow former Senator and elder statesman Gary Hart (D-CO), chaired the panel, and both Rudman and Hart have been lauded since September 11 for their chillingly prescient conclusions.